<DOC>
	<DOCNO>NCT00002858</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one chemotherapy drug radiation therapy may kill tumor cell . It yet know treatment regimen effective small cell lung cancer . PURPOSE : Randomized phase III trial study effectiveness combination chemotherapy use two different dos cyclophosphamide follow alternate chemotherapy radiation therapy treat patient small cell lung cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare effect 2-year disease-free survival two different dos cyclophosphamide part first induction chemotherapy follow alternate chemotherapy chest irradiation patient limited stage small cell lung cancer . OUTLINE : This randomize study . Patients stratify participate institution . All patient receive 2 course induction chemotherapy doxorubicin , etoposide , cisplatin , cyclophosphamide . For first course , one group patient receive low dose cyclophosphamide group . Both group receive , still low , dose cyclophosphamide second course . Beginning 1 week completion induction therapy , patient receive 3 alternating course radiotherapy mediastinal supraclavicular area deliver 10-12 day chemotherapy second course induction . Each course initiate 1-week rest . Patients receive final chemotherapy course begin 4 week previous chemotherapy course . Patients follow every 6 month survival . PROJECTED ACCRUAL : A total 280 patient enter .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven small cell lung cancer distant metastases Size initial lesion suitable total irradiation Positive subclavicular node allow No malignant pleural effusion No extension contralateral lung PATIENT CHARACTERISTICS : Age : Under 70 Performance status : Karnofsky 60 % 100 % Hematopoietic : WBC great 2,000 Platelets great 125,000 Hepatic : Not specify Renal : Creatinine le 1.1 mg/dL ( 100 micromoles/L ) Cardiovascular : No myocardial infarction within 6 month No cardiovascular disease precludes protocol treatment Other : No hearing loss No prior concurrent malignancy except : Basal cell skin carcinoma In situ carcinoma cervix Accessible followup PRIOR CONCURRENT THERAPY : No prior chemotherapy , radiotherapy , surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>limited stage small cell lung cancer</keyword>
</DOC>